Status:
COMPLETED
The Efficacy of 20 mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgery
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Anesthesia; Functional
Anesthesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This clinical trial aims to investigate the efficacy of 20 mg Parecoxib when it is given as an addition to 20 ml 0.75% ropivacaine in patients receiving ultrasound-guided supraclavicular brachial plex...
Detailed Description
Brachial plexus block (BPB) has enjoyed ubiquitous popularity for upper limb surgeries.There are a few common techniques for BPB and one of the most frequently-utilised one is supraclavicular BPB sinc...
Eligibility Criteria
Inclusion
- American Society of Anaesthesiology Physical Status Gred 1 and 2
- Expected duration of surgery is between 1 and 4 hours
Exclusion
- Subjects who refused brachial plexus block
- Know allergies to parecoxib, other NSAID and anaesthetic agents
- Pregnancy
- Prior history of brachial plexus injury
- Chronic pain history which long term use of analgesic medications
- Coagulopathy
- Systemic or local infection at the injection site
- Known neuropathy affecting the limb which undergo the surgical procedures
Key Trial Info
Start Date :
June 20 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 19 2017
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03480165
Start Date
June 20 2016
End Date
September 19 2017
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universiti Sains Malaysia (HUSM)
Kubang Kerian, Kelantan, Malaysia, 15350